Local view for "http://purl.org/linkedpolitics/eu/plenary/2006-12-11-Speech-1-181"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20061211.17.1-181"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
".
Mr President, I welcome the interest shown by the Members in the proposal to modify what we call the veterinary fund. I appreciate that the overall principles of the proposal have been accepted by Parliament.
The suggestions made are good ones but many of those are already being applied. The idea, for example, to allow emergency expenditure in a crisis is indeed essential, but the provision already exists in the decision under Article 3. The Commission funds actions to deal with those diseases on an emergency basis, normally at 50% co-financing of eligible measures and 60% for foot-and-mouth disease.
The idea of ensuring coordination between Member States submitting programmes is also welcome but this is also the case in reality. We will continue that approach but we feel that Article 16 is not the proper location. We will introduce the idea somewhere else – the idea of task forces and sharing best practice.
The eradication plans are publicly available on the Commission’s website, but we would be very happy to provide information on progress to Parliament and the Council and we recommend these to the Member States.
The decision sets out the criteria that Member States must fulfil when submitting eradication programmes to the Commission for consideration. Those are technical criteria. Therefore the regulatory committee procedure is appropriate to define the information required. Member States need to be very precise in the information they supply and it is therefore helpful for the Commission to specify the format required.
On the suggestion to delay the final date for submitting an application for funding, we encourage Member States to submit applications as early in the year as possible. Nevertheless, we can accept a final date of 30 April.
With regard to the list of diseases eligible to receive funding, which was raised by many speakers, we have proposed shortening the list to focus efforts on the key priorities: those diseases that have indirect implications for human health and diseases that may lead to serious trade problems. The addition of diseases or wider possibilities to allow Member States to submit any programme at all would risk dilution of those priorities. Nevertheless many of the diseases and issues raised will be or are being covered differently, for example, through the emergency expenditure (Article 3 of the decision). It covers those diseases that have the potential to cause very serious losses, such as classical swine fever, avian influenza or FMD, for example.
There are, however, two diseases on the list today, for which Member States currently receive funding: Aujeszky’s disease and bovine leucosis. For those two cases I am prepared to examine ways in which funding can continue for a number of years.
A full list of the Commission’s position on each of the amendments will be provided to Parliament. I trust that they will be included in the record of the sitting."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples